APOE and Alzheimer disease: While the current clinical guidelines do not always positively support APOE testing services, they may have potential benefits leading to positive health-related behaviors (Marshe et al. 2019), and they should not be restricted from the aspect of individual patients’ right to know their own genetic risk of having AD in the future.